Work

The Use of Parabulbar and Sub‐Tenon Injections to Correct Isolated Resistant Diplopia in Patients With Generalized Myasthenia Gravis: A Long Road to Clinically Meaningful Success

Year: 2025

Type: article

Abstract: Parabulbar betamethasone provided rapid and durable relief of isolated, treatment-resistant diplopia in seronegative myasthenia gravis after multiple systemic therapy failures, suggesting that targeted periocular corticosteroid delivery may be a steroid-sparing option for carefully selected patients when standard treatments are ineffective and close ophthalmic monitoring is available.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.71573

Authors: M. Marchuk, V. Sanin, V. Mamilov, M. Zinchenko

Institutions: Bogomolets National Medical University, Kyiv National Economic University named after Vadym Hetman

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820